Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy. Hage C, Hoves S, Ashoff M, Schandl V, et al. PLoS One 2019;14:e0219517.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hage C, Hoves S, Ashoff M, Schandl V, et al. Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy. PLoS One 2019;14:e0219517.
PMID: 31291357